Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A26445 | 20460913 | Dig Dis | The role of non-alcoholic fatty liver disease in cardiovascular disease. | 2010 | Details |
| A26446 | 20460912 | Dig Dis | Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. | 2010 | Details |
| A26448 | 20460910 | Dig Dis | Chemokines as immune mediators of liver diseases related to the metabolic syndrome. | 2010 | Details |
| A26449 | 20460909 | Dig Dis | Metabolic factors and non-alcoholic fatty liver disease as co-factors in other liver diseases. | 2010 | Details |
| A26450 | 20460908 | Dig Dis | The role of cytokines in non-alcoholic fatty liver disease. | 2010 | Details |
| A26451 | 20460907 | Dig Dis | Environmental and genetic determinants of fatty liver in humans. | 2010 | Details |
| A26453 | 20460905 | Dig Dis | Epidemiology of non-alcoholic fatty liver disease. | 2010 | Details |
| A26454 | 20459941 | S Afr Med J | Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: a descriptive analysis. | 2010 | Details |
| A26455 | 20459722 | BMC Public Health | Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. | 2010 | Details |
| A26459 | 20456209 | Int J Clin Pract | Report of the international symposium: polycystic ovary syndrome: first Latin-American consensus. | 2010 | Details |
| A26463 | 20448542 | Obesity (Silver Spring) | Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease. | 2010 | Details |
| A26468 | 20432259 | Hepatology | Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. | 2010 | Details |
| A26469 | 20432253 | Hepatology | Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. | 2010 | Details |
| A26471 | 20426802 | Lipids Health Dis | The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). | 2010 | Details |
| A26473 | 20422882 | Hepatogastroenterology | Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD. | 2010 | Details |
| A26478 | 20415685 | Diabetes Obes Metab | The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. | 2010 | Details |
| A26479 | 20414104 | Blood Press Monit | Aortic elastic properties in nonalcoholic fatty liver disease. | 2010 | Details |
| A26483 | 20388946 | J Physiol Pharmacol | Therapy of nonalcoholic fatty liver disease: current status. | 2009 | Details |
| A26485 | 20407430 | Am J Gastroenterol | A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease. | 2010 | Details |
| A26489 | 20402293 | Coll Antropol | Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity. | 2010 | Details |
| A26493 | 20398645 | Clin Biochem | Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. | 2010 | Details |
| A26499 | 20392512 | J Hepatol | Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model. | 2010 | Details |
| A26502 | 20388084 | Curr Pharm Des | Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. | 2010 | Details |
| A26503 | 20387643 | Ukr Biokhim Zh (1999) | Nonalcoholic fatty liver disease: biochemical and therapeutic considerations. | 2010 | Details |
| A26507 | 20379797 | Obes Surg | The decrease of serum levels of human neutrophil alpha-defensins parallels with the surgery-induced amelioration of NASH in obesity. | 2010 | Details |
| A26509 | 20375640 | Korean J Hepatol | [Validity and reliability of the nonalcoholic fatty liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors]. | 2010 | Details |
| A26512 | 20372110 | Am J Gastroenterol | Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. | 2010 | Details |
| A26516 | 20370678 | Curr Pharm Des | Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis. | 2010 | Details |
| A26517 | 20370677 | Curr Pharm Des | Insulin resistance in nonalcoholic fatty liver disease. | 2010 | Details |
| A26519 | 20370674 | Curr Pharm Des | Role of microRNAs in non-alcoholic steatohepatitis. | 2010 | Details |
| A26521 | 20370671 | Curr Pharm Des | Current and future therapeutic strategies in NAFLD. | 2010 | Details |
| A26522 | 20370670 | Curr Pharm Des | Retinol-binding protein 4 and new adipocytokines in nonalcoholic fatty liver disease. | 2010 | Details |
| A26524 | 20368747 | Clin Lipidol | Mechanisms and clinical implications of hepatocyte lipoapoptosis. | 2010 | Details |
| A26525 | 20368739 | Nat Rev Gastroenterol Hepatol | The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. | 2010 | Details |
| A26526 | 20037278 | Korean J Hepatol | Current status of liver disease in Korea: nonalcoholic fatty liver disease. | 2009 | Details |
| A26527 | 20361370 | Chirurg | [Indications and principles of metabolic surgery]. | 2010 | Details |
| A26528 | 20357081 | J Nutr | Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. | 2010 | Details |
| A26529 | 20355234 | World J Gastroenterol | Liver fat content determined by magnetic resonance imaging and spectroscopy. | 2010 | Details |
| A26530 | 20355232 | World J Gastroenterol | Ezetimbe as potential treatment for cholesterol gallstones: the need for clinical trials. | 2010 | Details |
| A26531 | 20353583 | J Inflamm (Lond) | Elevated endotoxin levels in non-alcoholic fatty liver disease. | 2010 | Details |
| A26533 | 20347174 | J Hepatol | Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. | 2010 | Details |
| A26534 | 20308723 | Ann Hepatol | High ghrelin and obestatin levels and low risk of developing fatty liver. | 2010 | Details |
| A26538 | 20303351 | Gastroenterology | Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. | 2010 | Details |
| A26541 | 20299294 | Prim Care Diabetes | Non-Alcoholic Fatty Liver Disease (NAFLD): new challenge for general practitioners and important burden for health authorities? | 2010 | Details |
| A26547 | 20227260 | Nutr Metab Cardiovasc Dis | Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients. | 2010 | Details |
| A26548 | 20226139 | Zhong Xi Yi Jie He Xue Bao | [Pathogenesis and treatment of non-alcoholic fatty liver disease]. | 2010 | Details |
| A26549 | 20222991 | Lipids Health Dis | NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26552 | 20221393 | PLoS One | Role of alcohol metabolism in non-alcoholic steatohepatitis. | 2010 | Details |
| A26553 | 20216561 | Eur J Clin Nutr | Dietary and physical activity patterns in children with fatty liver. | 2010 | Details |
| A26557 | 20207596 | Dig Liver Dis | From the metabolic syndrome to NAFLD or vice versa? | 2010 | Details |
| A26558 | 20206411 | Gastroenterol Hepatol | [Obesity and liver disease]. | 2010 | Details |
| A26564 | 20203061 | Am J Physiol Gastrointest Liver Physiol | Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. | 2010 | Details |
| A26571 | 20189787 | Prostaglandins Leukot Essent Fatty Acids | Fatty liver: role of inflammation and fatty acid nutrition. | 2010 | Details |
| A26572 | 20188144 | Biochim Biophys Acta | Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFbeta1. | 2010 | Details |
| A26573 | 20186137 | Obesity (Silver Spring) | Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program. | 2010 | Details |
| A26574 | 20185414 | J Lipid Res | Dietary fatty acids modulate antigen presentation to hepatic NKT cells in nonalcoholic fatty liver disease. | 2010 | Details |
| A26577 | 20179669 | Int J Obes (Lond) | Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study. | 2010 | Details |
| A26578 | 20176643 | Gut | Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. | 2010 | Details |
| A26582 | 20168226 | Curr Opin Gastroenterol | Recent advances in nonalcoholic fatty liver disease. | 2010 | Details |
| A26583 | 20165979 | Dig Dis Sci | Protective role of coffee in non-alcoholic fatty liver disease (NAFLD). | 2010 | Details |
| A26584 | 20164781 | Eur J Gastroenterol Hepatol | The role of nutritional profile in the orexigenic neuropeptide secretion in nonalcoholic fatty liver disease obese adolescents. | 2010 | Details |
| A26586 | 20158939 | Proc Nutr Soc | Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome. | 2010 | Details |
| A26591 | 20143458 | World J Gastroenterol | Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease? | 2010 | Details |
| A26592 | 20142825 | Int J Obes (Lond) | Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients. | 2010 | Details |
| A26597 | 20128971 | Zhonghua Gan Zang Bing Za Zhi | [Metabolic characteristics of a fatty liver disease model induced by high-fat feeding in young rats]. | 2010 | Details |
| A26603 | 20111022 | Obesity (Silver Spring) | Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat. | 2010 | Details |
| A26606 | 20101871 | Acta Clin Belg | Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics. | 2010 | Details |
| A26608 | 20101463 | Dig Dis Sci | Nonalcoholic fatty liver disease: a review and update. | 2010 | Details |
| A26609 | 20096896 | Metabolism | Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis. | 2010 | Details |
| A26611 | 20095887 | Scand J Gastroenterol | Serum chemerin and vaspin in non-alcoholic fatty liver disease. | 2010 | Details |
| A26612 | 20093562 | Am J Physiol Gastrointest Liver Physiol | The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. | 2010 | Details |
| A26613 | 20093511 | Radiology | Presence of coronary plaques in patients with nonalcoholic fatty liver disease. | 2010 | Details |
| A26615 | 20088867 | Liver Int | The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. | 2010 | Details |
| A26617 | 20087305 | J Sports Med Phys Fitness | Aerobic exercise and non-alcoholic fatty liver disease: a case report. | 2009 | Details |
| A26618 | 20085121 | Eur Rev Med Pharmacol Sci | Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients. | 2010 | Details |
| A26620 | 20082871 | Arch Med Res | High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease. | 2009 | Details |
| A26624 | 20079327 | Zhonghua Nei Ke Za Zhi | [Insulin resistance and islet beta cell function in type 2 diabetes mellitus and non alcoholic fatty liver disease.]. | 2009 | Details |
| A26625 | 20078219 | Annu Rev Pathol | Nonalcoholic fatty liver disease: pathology and pathogenesis. | 2010 | Details |
| A26627 | 20074156 | J Gastroenterol Hepatol | Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps. | 2010 | Details |
| A26628 | 20066503 | Obes Surg | Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients. | 2010 | Details |
| A26631 | 20059344 | Annu Rev Med | Emerging molecular targets for the treatment of nonalcoholic fatty liver disease. | 2010 | Details |
| A26635 | 20045153 | Metabolism | Plasma apelin levels in subjects with nonalcoholic fatty liver disease. | 2009 | Details |
| A26638 | 20042103 | Lipids Health Dis | Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. | 2009 | Details |
| A26642 | 24149634 | J Sports Sci Med | Association of cardiorespiratory fitness with elevated hepatic enzyme and liver fat in Japanese patients with impaired glucose tolerance and type 2 diabetes mellitus. | 2010 | Details |
| A26650 | 21442055 | Hepatol Int | Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients. | 2010 | Details |
| A26651 | 21387764 | Przegl Lek | [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers]. | 2010 | Details |
| A26652 | 20041406 | Hepatology | Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. | 2010 | Details |
| A26656 | 20038265 | Immunopharmacol Immunotoxicol | Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells. | 2010 | Details |
| A26659 | 20033348 | Obes Surg | SIRT1 transcription is decreased in visceral adipose tissue of morbidly obese patients with severe hepatic steatosis. | 2009 | Details |
| A26667 | 20022856 | Adv Med Sci | Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease. | 2009 | Details |
| A26669 | 20022466 | Nutrition | Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. | 2009 | Details |
| A26677 | 20001571 | Gynecol Endocrinol | Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role? | 2010 | Details |
| A26679 | 19961393 | Clin Chem Lab Med | Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. | 2010 | Details |
| A26680 | 19961041 | Eur Rev Med Pharmacol Sci | Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease. | 2010 | Details |
| A26682 | 19958640 | Zhonghua Gan Zang Bing Za Zhi | [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease]. | 2009 | Details |
| A26684 | 19957147 | Methods Mol Biol | Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new? | 2010 | Details |
| A26689 | 19948145 | Curr Biol | An emerging role of mTOR in lipid biosynthesis. | 2009 | Details |
| A26691 | 19946731 | J Gastroenterol | Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. | 2009 | Details |
| A26693 | 19945407 | Cell Metab | Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. | 2009 | Details |
| A26694 | 19942238 | Metabolism | Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy. | 2009 | Details |